Pharmaceutical launch across multiple countries
A two-drug combination with blockbuster potential for heart failure was granted priority review designation by the FDA. Therefore, the large pharmaceutical company which owns the product needed to urgently accelerate the pre-launch preparations across all geographies worldwide. These preparations included building specialty capabilities in a cardiovascular franchise that lacked them.
I coordinated the Go-To-Market strategy and pre-launch preparations for all countries in the Latin America and Canada region. I traveled extensively throughout the Americas working closely with all the local markets, as well as frequent Global meetings in Switzerland and Europe. Key actions included: serve as main point of contact between Country and Global teams; coordinating the cross functional teams; building specialty product capabilities in cardiovascular teams; identifying financial goals of revenue growth. All major markets in the Region were ready at the time of regulatory approvals with strong Launch Readiness Plans specific for their markets and aligned with the global strategy and branding. The two-drug combination (Entresto) achieved highly successful launches, including adequate Market Access with public and private payors across the Region. It is now an important treatment option for patients with Heart Failure for the markets in Latin America and Canada and a major blockbuster product.